WINT: Windtree Therapeutics, Inc. Stock

by  •  • Comments Off on WINT: Windtree Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1.13
Enterprise Value ($M) -0.73
Book Value ($M) 4.41
Book Value / Share 0.49
Price / Book 0.26
NCAV ($M) -22.11
NCAV / Share -2.46
Price / NCAV -0.05

Profitability (mra)
Return on Invested Capital (ROIC) -1.59
Return on Assets (ROA) -0.30
Return on Equity (ROE) -2.86

Liquidity (mrq)
Quick Ratio 0.27
Current Ratio 0.27

Balance Sheet (mrq) ($M)
Current Assets 3.93
Assets 30.45
Liabilities 26.04
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Flynn James E 0.00 -100.00
11-14 13G/A Lind Global Fund II LP 0.40 -94.44
11-14 13G Armistice Capital, Llc 7.12
02-14 13G/A Lincoln Park Capital Fund, LLC 6.18 -26.11

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 1,823,851 6,671,418 27.34
2025-02-03 164,436 1,201,193 13.69
2025-01-31 996,776 2,954,085 33.74
2025-01-30 411,586 1,848,694 22.26

(click for more detail)

Similar Companies
VTVT – vTv Therapeutics Inc. VXRT – Vaxart, Inc.
VYNE – VYNE Therapeutics Inc. XBIO – Xenetic Biosciences, Inc.
XCUR – Exicure, Inc.


Financial data and stock pages provided by
Fintel.io